AzTrials
AzTrials

ConstipationNCT02805959

Colonic Motility in Constipation and Aging: A Study With a New 3D Transit System

An observational study of Constipation, run by University of Aarhus.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To study the motility of the bowel in constipated patients. Looking at the difference between young and elderly patients with constipation. Read more about this study

Who is it for?
Ages 18 to 90 years, women onlyHealthy volunteers can take part
Conditions the study is for
Constipation
What is being tested?
MTS2
Type of treatment
Medical device
How many people
20 participants
Where
No sites listed yet
Study dates
Jun 2016to Apr 2017
How long will I take part?
1 Week
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Women with constipation

Who may be able to join

  • Constipation

Who cannot join

  • Constipation caused by other disease

About this study

Official title: Colonic Motility in Constipation and Aging: A Pilot Study With a New 3D Transit System

To study the motility of the bowel in constipated patients. Looking at the difference between young and elderly patients with constipation.

Conditions
Constipation
Being tested
MTS2
Medical subject headings
Constipation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MTS2Device

Study groups in NCT02805959
Study groupRoleWhat they receive
Constipated, ElderlyInvestigation with MTS for motility
Receives: Device: MTS2
Constipation, YoungInvestigation with MTS for motility
Receives: Device: MTS2
Normal Bowel, ElderlyInvestigation with MTS for motility
Receives: Device: MTS2
Normal Bowel, YoungInvestigation with MTS for motility
Receives: Device: MTS2

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Transit time through the small intestine and the colon. Both the total transit time, the regional transit times and the antegrade and retrograde movements are measured by the MTS system

    The measurements will all be at least three days long, but can be up to 5 days depending on the rate of bowel movements.

    Measured: The total transit time will differ between healthy and constipated but probably between 3-5 days.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jun 2016 (estimated)
  2. Study startJun 2016
  3. Primary completionApr 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Enrolment
20 participants (estimated)
Target duration
1 Week
IDs, dates and publications
ClinicalTrials.gov ID
NCT02805959
Sponsor's protocol ID
Fynne
Status last verified
Apr 2016
First submitted
4 May 2016
Last updated
21 Jun 2016
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Constipation, run by University of Aarhus.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Jun 2016. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Transit time through the small intestine and the colon. Both the total transit time, the regional transit times and the antegrade and retrograde movements are measured by the MTS system (time frame: The total transit time will differ between healthy and constipated but probably between 3-5 days.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jun 2016; AzTrials last refreshed its copy on 2 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in